Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | TNNI2 |
| Upstream (Parents) |
|---|
| (<<) MYL1 → TNNI2 |
| (<<) MYH2 → TNNI2 |
| (<<) TNNI1 → TNNI2 |
| Downstream (Children) |
|---|
| TNNI2 → EML2 (>>) |
| TNNI2 → LOC79999 (>>) |
| TNNI2 → MYLPF (>>) |
| TNNI2 → TPM1 (>>) |
| TNNI2 → RRAD (>>) |
| TNNI2 → WNT3 (>>) |
| TNNI2 → CSRP3 (>>) |
| TNNI2 → MYH2 (>>) |
| TNNI2 → MYBPC1 (>>) |
| TNNI2 → TNNI1 (>>) |
| TNNI2 → ACTN2 (>>) |
| TNNI2 → SLN (>>) |
| TNNI2 → HSPB3 (>>) |
